年内最高收益超1.5倍QDII基金业绩与规模双升

Core Insights - The QDII funds have become the top performers in the market, with the highest returns exceeding 1.5 times, significantly outperforming A-share funds [1][2] - As of the end of Q2 this year, the total scale of public QDII funds reached approximately 680 billion yuan, marking a historical high [2][3] Performance and Scale Growth - The QDII funds benefited from a robust liquidity environment, leading to a strong valuation recovery in the Hong Kong stock market, which in turn drove performance gains [2] - The top-performing QDII funds include Huatai-PB Hong Kong Advantage Selection, E Fund Global Pharmaceutical Industry, ICBC New Economy, and Southern Hong Kong Pharmaceutical Industry [2] - The total scale of public QDII funds has increased by 11.4% compared to the end of 2024, growing from approximately 93 billion yuan at the end of 2019 to nearly 700 billion yuan now [2][3] Stock Selection Advantages - QDII funds have a significant advantage in stock selection due to fewer restrictions compared to A-share and Hong Kong Stock Connect funds, which are limited to stocks on the Hong Kong Stock Connect list [3][4] - For instance, Tencent Music, which has seen its stock price rise by nearly 1.3 times this year, is not included in the Hong Kong Stock Connect list, allowing QDII funds to invest in it [3] - The flexibility in investment opportunities allows QDII funds to capture diverse returns, as the profit effect has spread from Hong Kong Stock Connect companies to non-Hong Kong Stock Connect companies [4] Future Investment Opportunities - QDII fund managers are optimistic about growth opportunities in new consumption and new technology sectors [5] - Investment strategies should focus on understanding consumer interest changes and increasing allocations to high-end manufacturing and cultural exports [6] - The AI industry chain is highlighted as a key investment opportunity, with expectations of significant growth driven by advancements in AI technology and its applications [6]